VAV1 and neoplasm: However, our present data puts a note of caution on those possible avenues, since they indicate that the blockage of Vav family–dependent signaling could be highly counterproductive in the case of lymphoblastic lymphoma patients with reduced levels of RASGRF2 gene expression in tumor cells.